Cargando…
Mifepristone (RU-486(®)) as a Schedule IV Controlled Drug—Implications for a Misleading Drug Policy on Women’s Health Care
Background: Mifepristone (RU-486) has been approved for abortion in Taiwan since 2000. Mifepristone was the first non-addictive medicine to be classified as a schedule IV controlled drug. As a case of the “misuse” of “misuse of drugs laws,” the policy and consequences of mifepristone-assisted aborti...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9323789/ https://www.ncbi.nlm.nih.gov/pubmed/35886217 http://dx.doi.org/10.3390/ijerph19148363 |